BioMed Research International / 2014 / Article / Tab 6

Clinical Study

Dialysis Complications in AKI Patients Treated with Extended Daily Dialysis: Is the Duration of Therapy Important?

Table 6

Initial and final dose of vasoactive drugs and blood pressure according to the different duration of sessions.

G1 = 6 h ( sessions)G2 = 10 h ( sessions) value
S1 ()S2 ()S3 ()S1 ()S2 ()S3 ()

Initial VAD0.55 ± 0.5d0.68 ± 0.6d0.52 ± 0.3d0.53 ± 0.2a,d0.59 ± 0.4b,d0.61 ± 0.4c,dNS
Final VAD0.70 ± 0.50.78 ± 0.70.64 ± 0.50.74 ± 0.4a0.75 ± 0.6b0.70 ± 0.5cNS
SBP start118 ± 23e128 ± 28e113 ± 27e128 ± 23a,e114 ± 29b,e128 ± 26c,eNS
DBP start67 ± 16f64 ± 16f56 ± 14f68 ± 15a,f64 ± 18b,f68 ± 13c,fNS
SBP end114 ± 26121 ± 27136 ± 13124 ± 22a133 ± 23b123 ± 17cNS
DBP end63 ± 1665 ± 1569 ± 1768 ± 15a73 ± 15b67 ± 9cNS

Amounts shown in mean and standard deviation.
VAD: vasoactive drug, EDD: extended daily dialysis, SBP: systolic blood pressure, and DBP: diastolic blood pressure.
aSimilar to S1 of G1.
bSimilar to S2 of G1.
cSimilar to S3 of G1.
dDifferent from VAD end, .
eDifferent from SBP end, .
fDifferent from DBP end, .
NS: not significant ().